Long‐term safety and efficacy of nalmefene in Japanese patients with alcohol dependence-Reference-Cited by-同舟云学术

Long‐term safety and efficacy of nalmefene in Japanese patients with alcohol dependence

Published:2020-05-27 Issue:8 Volume:74 Page:431-438
ISSN:1323-1316
Container-title:Psychiatry and Clinical Neurosciences
language:en
Short-container-title:Psychiatry Clin. Neurosci.

Author:

Higuchi Susumu¹,Takahashi Masayoshi²,Murai Yoshiyuki²,Tsuneyoshi Kana³,Nakamura Izuru⁴^ORCID,Meulien Didier⁵,Miyata Hisatsugu⁶

Affiliation:

1. National Hospital Organization, Kurihama Medical and Addiction Center Yokosuka Japan

2. Department of Clinical Management, Clinical Development HeadquartersOtsuka Pharmaceutical Co., Ltd. Tokyo Japan

3. Department of Biometrics, Clinical Development HeadquartersOtsuka Pharmaceutical Co., Ltd. Osaka Japan

4. Medical AffairsOtsuka Pharmaceutical Co., Ltd. Tokyo Japan

5. Clinical Research and DevelopmentH. Lundbeck A/S Valby Denmark

6. Department of PsychiatryJikei University School of Medicine Tokyo Japan

Funder

H. Lundbeck A/S

Otsuka Pharmaceutical

Publisher

Wiley

Subject

Psychiatry and Mental health,Neurology (clinical),Neurology,General Medicine,General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/pcn.13017

Reference20 articles.

1. Prevalence and Trends in Alcohol Dependence and Alcohol Use Disorders in Japanese Adults; Results from Periodical Nationwide Surveys

2. Initial Preference for Drinking Goal in the Treatment of Alcohol Problems: I. Baseline Differences Between Abstinence and Non-Abstinence Groups

3. European Medicines Agency Committee for Medicinal Products for Human Use (CHMP). Guideline on the development of medicinal products for the treatment of alcohol dependence. European Medicines Agency; 2010. [Cited 19 June 2017.] Available from URL:http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2010/03/WC500074898.pdf

4. The American Psychiatric Association Practice Guideline for the Pharmacological Treatment of Patients With Alcohol Use Disorder

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment of liver cirrhosis in the era of steatotic liver disease;Hepatology Research;2024-05-28

2. Emerging drugs in phase II and III clinical development for the treatment of alcohol use disorder;Expert Opinion on Emerging Drugs;2024-04-18

3. Efficacy and safety of alcohol reduction pharmacotherapy according to treatment duration in patients with alcohol dependence or alcohol use disorder: A systematic review and network meta‐analysis;Addiction;2024-01-03

4. Nalmefene combined noninvasive positive-pressure ventilation in Chinese patients with chronic obstructive pulmonary disease coupled with type II respiratory failure: A meta-analysis;Medicine;2023-08-04